Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2026-02-22 @ 6:43 PM
Study NCT ID:
NCT05185804
Status:
COMPLETED
Last Update Posted:
2022-01-11
First Post:
2021-12-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19
Sponsor:
PharmaDiall Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Dimolegin | View |
| None | Dioxaban | View |
| None | DD217 | View |
| None | factor Xa Inhibitor | View |
| None | anticoagulant | View |
| None | therapeutic anticoagulation | View |
| None | thromboprophylaxis | View |
| None | anticoagulation | View |
| None | venous thromboembolism | View |
| None | deep venous thrombosis | View |
| None | arterial thromboembolism | View |
| None | pulmonary embolism | View |